TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A 2026 paper in The Lancet Healthy Longevity argues that sarcopenia and age-related mobility loss should be understood as problems involving the whole motor system, not muscle alone. The researchers propose changes to assessment and research, but say the suggested measures have not yet been shown to outperform current screening or improve outcomes.
Researchers writing in The Lancet Healthy Longevity argue that age-related weakness and mobility loss should not be treated as muscle problems alone, proposing that changes across the aging motor system also help explain declining strength and movement. Their paper calls for broader assessment and research, but the authors say it remains unproven whether the proposed measures improve outcomes over existing screens.
The paper, by Lucas B. R. Orssatto and colleagues, says the established account of sarcopenia has not kept pace with how the condition is measured. While the term has traditionally been linked to loss of muscle, diagnosis has increasingly emphasized grip strength, walking speed and chair stands—measures of physical function that can predict outcomes such as falls, disability and death better than muscle mass alone, according to the report.
The authors argue that muscle loss explains only a modest share of the decline in strength among older adults. They point to differences in strength and mobility between people with similar amounts of muscle, and to evidence cited in the paper that exercise can improve strength and mobility without a measurable increase in muscle mass. They say these findings suggest that muscle size alone does not account for changes in everyday function.
Instead, the researchers propose looking at the motor system as a whole: the brain and spinal cord, nerves, the connections between nerves and muscles, and muscle tissue. They describe aging-related changes that may affect movement planning, signal transmission, balance and position sense. This is the paper’s proposed explanation, not proof that a single motor-system mechanism accounts for every person’s weakness.
Why Broader Weakness Checks Matter
The proposed reframing could affect how clinicians investigate an older person’s loss of strength and how researchers judge whether treatments work. If weakness reflects more than muscle mass, an approach focused chiefly on building muscle may miss other contributors to slower movement, poor balance or reduced coordination. The paper argues for research and care that measure practical function as well as muscle.
That question carries particular weight in Australia, where falls are a major health burden. The Medical Xpress report, citing national figures, says there were 253,800 fall-related hospitalizations in 2024–25. It also reports that 6,722 Australians died following a fall in the preceding year and that fall injuries cost the health system an estimated $5.4 billion. Those figures describe the broader stakes; they do not show that the paper’s proposed approach would prevent falls.
For primary care, the authors suggest noticing how quickly a patient rises from a chair, whether they become unsteady during sustained effort, and whether hand dexterity or walking changes when the person also talks. They also say clinicians should examine weakness more closely if it is asymmetric, rapid or disproportionate to apparent muscle loss. These are proposed assessment considerations, not a validated replacement for existing screening.
Products Worth Considering
Fitbit Sense Advanced Smartwatch – Sage Grey/Silver (One Size, S & L Bands Included)
Fitbit Versa Smart Watch – Black Aluminum, One Size (S & L Bands Included)
BowFlex Results Series SelectTech 552 Adjustable Dumbbell
As an affiliate, we earn on qualifying purchases.
How Sarcopenia Assessment Has Shifted
Sarcopenia refers to substantial loss of muscle, strength and physical function associated with aging. The Medical Xpress report says it affects up to 29% of older adults living in the community, with higher rates in hospitals and residential aged care, and among people with multiple health conditions or frailty. Rates depend on the population and setting described.
Screening guidance is also developing. Earlier in 2026, the Australian Journal of General Practice published a proposed algorithm for screening, assessing and managing poor muscle health in primary care, according to Medical Xpress. The new paper raises a related question: whether the explanation and assessment of sarcopenia should reflect the fact that functional measures have become central to diagnosis.
The authors say power—the ability to produce force quickly—can decline earlier and faster with age than muscle mass. Rising from a chair, for example, requires speed and coordination as well as strength. They argue that how effectively nerves recruit and drive muscle fibers may influence performance on such tasks, reinforcing their case for research that considers nerve function alongside muscle.
“Reframing sarcopenia as a disease of the ageing motor system”
— Lucas B. R. Orssatto and colleagues, in their paper in The Lancet Healthy Longevity
Which New Tests Still Need Proof
The authors acknowledge that the suggested measures have not been shown to outperform existing screens on health outcomes or cost. The source does not report a trial establishing that a motor-system assessment prevents falls, preserves independence or improves treatment decisions. It also does not establish how often nerve-related changes, rather than other health factors, account for an individual’s weakness.
Access to clinicians with neuromuscular expertise is uneven in primary care, the authors say. Practical testing, training needs and the usefulness of adding measures such as dexterity or dual-task walking are still unresolved. The paper calls for validation rather than claiming that the proposed approach is ready to replace current criteria.
The report also notes medication review, including attention to sedative and anticholinergic medicines that may blunt motor drive. The material provided does not quantify how much these medicines contribute to mobility loss in older adults or establish a specific medication-management protocol. Decisions about medication or evaluation should be made with a qualified health professional.
Research Needed Before Practice Changes
The authors set out a five-point agenda for international working groups that develop sarcopenia diagnostic criteria. They call for investment in practical tests that can be validated, guidelines that support a staged assessment, and trials that measure nerve function as well as muscle. The report does not give a timetable for when those groups might consider changes.
For now, the proposal is a research and clinical discussion rather than a new standard of care. The next evidence needed is whether broader assessments identify meaningful causes of weakness that current screens miss, whether those findings change treatment, and whether any resulting changes improve mobility, reduce falls or preserve independence. Until those questions are tested, the authors’ motor-system framing remains a proposal.
Key Questions
What is sarcopenia?
Sarcopenia is substantial loss of muscle, strength and physical function associated with aging. The paper argues that its assessment should account for more than muscle mass alone.
What does the motor-system explanation add?
It considers the brain, spinal cord, nerves, their connections to muscles and the muscles themselves. The researchers say changes across this system may contribute to weakness and reduced mobility, but the proposal still needs testing.
Are the proposed checks ready to replace current screening?
No. The authors say the additional measures have not been shown to outperform existing screens on outcomes or cost. They call for validation and clinical trials before practice standards change.
Why does the paper discuss falls?
Falls are a major consequence associated with weakness and reduced mobility. Medical Xpress reports 253,800 fall-related hospitalizations in Australia in 2024–25, but the paper does not show that its proposed assessment would prevent falls.
Source: medicalxpress.com
